Comparison of Incidence of Back Pain

Sponsor
Keimyung University Dongsan Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05082220
Collaborator
(none)
53
1
2
5.6
9.4

Study Details

Study Description

Brief Summary

Paramedian and midline approach are two methods for the epidural entry. After the procedure of epidural injection. there are patients complaing dull nature back pain. This study was designed to comapre the incidence of back pain after performance of thoracic epidural catheterization with paramedian and midline approach.

Condition or Disease Intervention/Treatment Phase
  • Procedure: epidural catheterization
N/A

Detailed Description

In previous studies, occurrence of back apin after epdiural or spinal anesthesia has been reported to have similar incidences with back pain after general anesthesia. The characteristics of this back pain is mild, localized in back pain without radiation, and improved within a few days. The risk factor for this back pain is lithotomy position, multiple attempt for regional block, operation more than 2.5 hour, BMI >32 and previous history of back pain. The proposed mechanism for this back pain is rupture of ligament or tendon during advance of needle, local hemorraghe due to friction with a bone, immobility of spine, relaxation of paraspinal muscle, and streching or straining of joint capsule.

Paramedian and midline approach are two methods for the epidural entry. When the midline approach is performed, the needle is inserted at the corresponding level of spinous process lower edge. The needle penetrates supraspinous ligaments, interspinous ligaments and ligamentum flavum sequentially. During paramedian approach, the needle is inserted 1cm below and 1 cm lateral to the spinous process. In constrast to midline approach, this method does not penetrate supraspinous and interspinous ligaments.

There is no study showing the differences of incidenece of back pain with midline or paramedian approach.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
53 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Incidence of Postoperative Back Pain Between Different Thoracic Epidural Approach Method
Actual Study Start Date :
May 12, 2021
Anticipated Primary Completion Date :
Oct 25, 2021
Anticipated Study Completion Date :
Oct 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: midline group

epidural catheterization with midline appraoch

Procedure: epidural catheterization
epidural catheterization using midline or paramedian approach

Active Comparator: paramedian group

epidural catheterization with paramedian approach

Procedure: epidural catheterization
epidural catheterization using midline or paramedian approach

Outcome Measures

Primary Outcome Measures

  1. Change from baseline back pain numeric rating scale at 1 month [Baseline, 1 month after operation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • liver lobectomy

  • gastrectomy

  • lung lobectomy

  • esophagectomy

Exclusion Criteria:
  • allergy to local anesthetics or contrast medium

  • pregnancy

  • infection

  • spine deformity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hong ji HEE Daegu Korea, Republic of 42601

Sponsors and Collaborators

  • Keimyung University Dongsan Medical Center

Investigators

  • Principal Investigator: Ji H Hong, Keimyung University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ji Hee Hong, Professor, Keimyung University Dongsan Medical Center
ClinicalTrials.gov Identifier:
NCT05082220
Other Study ID Numbers:
  • 2021-03-061
First Posted:
Oct 18, 2021
Last Update Posted:
Oct 18, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2021